Skip to main content
FinSpry Logo
FinSpry
BLLN logo
BLLN
(NASDAQ)
BillionToOne, Inc.
$79.36-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

BillionToOne (BLLN) Stock Price & Financial Analysis

BillionToOne Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$76.28 - $84.90
52-Week High$138.70
52-Week Low$61.96
Open$79.94
Volume362.71K
Average Volume (3M)362.71K
Market Cap3.55B
Shares Outstanding44.72M
Price to Sales (P/S)14.60
EV/EBITDA-9811.31
Revenue (TTM)254.14M
Net Income (TTM)-10.00M
Free Cash Flow (TTM)-4.07M
EPS (TTM)$-0.22
Profit Margin-3.93%
Operating Margin-2.36%
50-Day MA$79.48
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About BillionToOne

What is the current stock price for BLLN?

As of the latest trading session, BLLN stock trades at $79.36. The 52-week range is $61.96–$138.70, with a day range of $76.28–$84.90.

What is the P/E ratio for BLLN?

The P/E ratio (Price-to-Earnings) for BLLN is shown in the Key Statistics section. This valuation metric helps compare BillionToOne, Inc. to industry peers.

Does BLLN pay dividends?

BillionToOne does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BLLN?

Based on 5 analysts, the consensus for BLLN is Hold. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of BLLN?

BillionToOne's market capitalization is $3.55B, classifying it as a mid-cap company. BillionToOne operates in the Healthcare sector within the Diagnostics & Research industry.